# Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer

> **NCT04515004** · PHASE2 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 6 (actual)

## Conditions studied

- Early Stage Lung Cancer (I and II)

## Interventions

- **DRUG:** leucoselect phytosome

## Key facts

- **NCT ID:** NCT04515004
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-11-20
- **Primary completion:** 2024-11-01
- **Final completion:** 2025-03-31
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Early termination by sponsor due to substantial delays with subjects recruitment
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04515004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04515004, "Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04515004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*